Supernus Pharmaceuticals reported $12.14M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Abbott USD 2.07B 105M Jun/2025
ANI Pharmaceuticals USD 15.17M 10.3M Jun/2025
Aurora Cannabis CAD -17609000 54.46M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Canopy Growth CAD -31497000 7.68M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Eisai JPY 20.74B 1.77B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 2.21M Jun/2025
Perrigo USD 55.6M 91M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025
Xeris Pharmaceuticals USD 5.43M 3.75M Jun/2025